European Journal of Medicinal Chemistry · 2014 · 56 citations · 20 references
PharmacyInfectious DiseasesMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral Drug DesignAntiviral Structure-activity RelationshipsDengue FeverLead Compound ScreeningPyrazine ChemistryPyrazole ChemistryYellow Fever Virus
The results of a high-throughput screening assay using the dengue virus-2 replicon showed that the imidazole 4,5-dicarboxamide (I45DC) derivative (15a) has a high dengue virus inhibitory activity. Based on 15a as a lead compound, a novel class of both disubstituted I45DCs and the resembling pyrazine 2,3-dicarboxamides (P23DCs) were synthesized. Here, we report on their in vitro inhibitory activity against dengue virus (DENV) and yellow fever virus (YFV). Some of these first generation compounds have shown activity against both viruses in the micromolar range. Within this series, compound 15b was observed to display the highest antiviral potency against YFV with an EC50 = 1.85 μM. In addition, compounds 20a and 20b both potently inhibited replication of DENV (EC50 = 0.93 μM) in Vero cells.
20
The global distribution and burden of dengue
Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature · 2013 · 10.2K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +12
A Small-Molecule Dengue Virus Entry Inhibitor
Qingyin Wang, Sejal Patel, Eric Vangrevelinghe et al. · Antimicrobial Agents and Chemotherapy · 2009 · 208 citations · Full text